The scientists ultimately concluded that there was a lack of evidence to support BPC-157 as an ulcerative colitis treatment
Roughly 60 to 90 grams of glucose per day gets excreted in urine instead
Meta users are being bombarded with ads for shady generic Ozempic prescriptions Even though the FDA has made it clear that no generics currently exist Written by Olivia Little Research contributions from Sharon Kann Published Three weightloss telehealth companies are spending heavily to target Meta users with predatory ads selling prescriptions for bogus generic alternatives to popular weight loss drugs Ozempic, Wegovy, and Mounjaro despite the fact that generics of those medications do not currently exist
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study
Stacking two GLP-1 agonists amplifies gastrointestinal effects: severe nausea, vomiting, constipation, and appetite loss without additional weight loss
